PAYS - Paysign GAAP EPS of $0.02 revenue of $10.6M

• Paysign press release ( NASDAQ: PAYS ): Q3 GAAP EPS of $0.02.
• Revenue of $10.6M (+36.4% Y/Y).
• Outlook: "With the growth in the business we experienced in the third quarter and our expectations for continued growth in the fourth quarter, we expect total revenue for 2022 to be $38.15 million to $38.35 million, representing growth of 29-30% over 2021. Plasma is estimated to make up over 90% of total revenue for 2022."
• "We expect to end the year with over 445 plasma centers and over 20 active pharma prepaid programs. Full-year gross profit margins are expected to be approximately 56.0%, with operating expenses expected to be between $21.00 million and $21.25 million as we continue to invest in people and technology and experience higher costs in insurance, travel and entertainment and other inflationary pressures......Adjusted EBITDA is expected to be $5.50 million to $5.60 million," the management said.

For further details see: